Shoulder Innovations, Inc.

SI Healthcare Medical Devices

Shoulder Innovations, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $47.3 million, up 49.6% from fiscal 2024. In the quarter to June 2026, revenue grew 56.0%, EPS grew 99.7%, free cash flow fell 52.4% and total debt was flat, each against the same quarter a year earlier. Insiders bought in the last twelve months.

18.09 0.28 −1.52%
Market cap
$382.4M
P/E
0.0×
Fwd P/E
−8.4×
Dividend yield
—
F-score
n/a
Altman Z
2.53
Beneish M
−2.42
Dividend safety
n/a
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
P/E ratio
0.00 0.00 0.00 0.00

+5 more quarters

P/S ratio
7.00 5.57 2.62 4.23
P/FCF ratio
0.00 0.00 0.00 0.00
P/Operating CF
(56.89) (24.28) (14.12) (19.96)
P/B ratio
3.38 2.26 0.88 1.15
EV/Sales
5.60 3.83 0.31 1.20
EV/EBITDA
0.00 0.00 0.00 0.00
EV/FCF
(7.14) (4.72) (0.41) (1.65)
Current Ratio
10.71 11.81 11.07 11.09
Net Debt/EBITDA
9.51 12.01 14.67 18.18
Debt/Equity
0.12 0.11 0.11 0.10
Earnings Yield
(9.47%) (1,149.07%) (1,529.23%) (2,283.65%)
Free Cash Flow Yield
(11.19%) (14.59%) (29.04%) (17.14%)
Free Cash Flow per Share
(0.46) (0.73) (1.28) (0.84)
Book value per Share
6.00 6.44 16.23 10.87
Free Cash Flow
(9.55) (15.09) (11.06) (11.37)
EV/EBIT
0.00 0.00 0.00 0.00
Other line items

Show all line items

Columns are period end dates